Cytokinetics (CYTK)

Add to Watchlists
Create an Alert
9.52 +0.45  +4.96% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
CYTK Price Chart
View All Events

CYTK Events

Date Type Description
Feb 06 Misc Q4 2013 Cytokinetics, Inc. Earnings Conference Call
Feb 06 Earnings Q4 2013 Cytokinetics, Inc. Earnings. Estimate: -0.20.
Oct 30 Misc Q3 2013 Cytokinetics, Inc. Earnings Conference Call
Oct 30 Earnings Cytokinetics to Announce Third Quarter Results on October 30, 2013. Estimate: -0.09.
Jul 31 Misc Q2 2013 Cytokinetics, Inc. Earnings Conference Call
Jul 31 Earnings Q2 2013 Cytokinetics, Inc. Earnings Release. Estimate: -0.09.
Jun 25 Splits Ratio: 6006000463061293:36028797018963968
Apr 30 Misc Q1 2013 Cytokinetics, Inc. Earnings Conference Call
Apr 30 Earnings Cytokinetics to Announce First Quarter Results on April 30, 2013. Estimate: -0.08.
View All Performance Charts

CYTK Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cytokinetics is up 31.13% over the last year vs S&P 500 Total Return up 23.54%, Amgen up 7.42%, and Array BioPharma down 29.09%.

Get Quote for

Portfolio Strategies Featuring CYTK

Did Cytokinetics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CYTK Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Cytokinetics Inc is a clinical-stage biopharmaceutical company engaged in discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CYTK 9.52 +0.45 +4.96% 343.47M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.